vTv Therapeutics Inc (NASDAQ: VTVT) stock closed at $18.40 on 9/2/25 after a major increase of 13.3%. Moreover, this advance was accompanied by exceptionally high trading volume at 474% of normal. The stock has risen 15.0% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
vTv Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. vTv Therapeutics has a neutral Power Rating of 41 but a very low Appreciation Score of 8, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment